Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | June 01, 2007 | June 04, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date June 01, 2007 · Filed June 04, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $29.84 · Expires 2017-05-31 | Direct | 20,000 |
Reported balance
After 2007-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2007-06-01 · Grant · Acquired 20,000 · Balance 20,000 F1: Right to buy under 2006 Stock and Option Plan. Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy under 2006 Stock and Option Plan. Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2007 Filed Jun 4, 2007 16:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0000875320-07-000065 · edgar.xml · derivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2017-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-07-000056 · edgar.xml · derivative · entry 3 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $30.42 | $304,200.00 |
DisclosureSEC source: 0000875320-07-000056 · edgar.xml · nonDerivative · entry 2 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · balance_after: Dr. Slater disclaims beneficial ownership of 1,105 shares, which are held jointly with her adult son. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $13.32 | $133,200.00 |
DisclosureSEC source: 0000875320-07-000056 · edgar.xml · nonDerivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Dr. Slater disclaims beneficial ownership of 1,105 shares, which are held jointly with her adult son. Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 17:29 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $34.32 | $0.00 |
DisclosureSEC source: 0000875320-06-000052 · edgar.xml · derivative · entry 2 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 20,000 shares Expires 2016-05-31 F3 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| May 17, 2006 Filed Jun 2, 2006 17:29 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | PurchaseCommon Stock | 455 | $31.98 | $14,550.90 |
DisclosureSEC source: 0000875320-06-000052 · edgar.xml · nonDerivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · shares: These shares were purchased by and are held jointly with Dr. Slater's adult son, and Dr. Slater disclaims beneficial ownership of these shares. F2 · balance_after: Dr. Slater disclaims beneficial ownership of these shares, which are held jointly with her adult son. Read SEC document |
| March 23, 2006 Filed Mar 27, 2006 17:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | PurchaseCommon Stock | 650 | $36.00 | $23,400.00 |
DisclosureSEC source: 0000875320-06-000032 · edgar.xml · nonDerivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 F1 · shares: 325 of these shares are held jointly with each of her two children, and Dr. Slater disclaims beneficial ownership of these shares. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 15:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-05-000030 · edgar.xml · derivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2004 Filed Jun 2, 2004 15:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $9.09 | $0.00 |
DisclosureSEC source: 0000875320-04-000068 · edgar.xml · derivative · entry 1 Slater Eve Elizabeth · CIK 0001289739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 7,500 shares Expires 2014-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.